Comparative Metabolomics Unveils Molecular Changes and Metabolic Networks of Syringin Against Hepatitis B Mice by Untargeted Mass Spectrometry

Overview

Journal RSC Adv

Publisher Royal Society of Chemistry

Specialty Chemistry

Date 2022 May 2

PMID 35492557

Authors

Yi-Chang Jiang

Yuan-Feng Li

Ling Zhou

Da-Peng Zhang

Affiliations

Soon will be listed here.

Abstract

Untargeted metabolomics technology was used to discover the metabolic pathways and biomarkers for revealing the potential biological mechanism of syringin on hepatitis B virus. Serum samples were analyzed by ultra-performance liquid chromatography-mass spectrometry (UPLC-MS)-based comparative metabolomics coupled with pattern recognition methods and network pathway. In addition, the histopathology, HBV DNA detection of liver tissue, and biochemical indicators of liver function change were also explored for investigating the antiviral effect of syringin. In comparison to the model group, the metabolic profiles of the turbulence in transgenic mice tended to recover to the same as the control group after syringin therapy. A total of 33 potential biomarkers were determined to explore the metabolic disorders in the hepatitis B animal model, of which 25 were regulated by syringin, and 8 metabolic pathways, such as phenylalanine, tyrosine and tryptophan biosynthesis, phenylalanine metabolism, arachidonic acid metabolism, glyoxylate and dicarboxylate metabolism, were involved. Syringin markedly reduced the liver pathology change, inhibited HBV DNA replication, and improved liver function. Amino acid metabolism is a potential target for the treatment of hepatitis B. The hepatoprotective effect of syringin may contribute to ameliorating oxidative stress and preventing protein and DNA replication. Comparative metabolomics is a promising tool for discovering metabolic pathways and biomarkers of the hepatitis B animal model as targets to reveal the effects and mechanism of syringin, which benefits the development of natural products and advances the treatment of diseases.

Citing Articles

Dietary Effects of Probiotic Bacteria, AV5 on Growth, Serum and Mucus Immune Response, Metabolomics, and Lipid Metabolism in Nile Tilapia ().

Shija V, Zakaria G, Amoah K, Yi L, Huang J, Masanja F Aquac Nutr. 2024; 2024:4253969.

PMID: 39555520 PMC: 11333138. DOI: 10.1155/2024/4253969.

Syringin: a naturally occurring compound with medicinal properties.

Qian Q, Pan J, Yang J, Wang R, Luo K, Wu Z Front Pharmacol. 2024; 15:1435524.

PMID: 39104400 PMC: 11298447. DOI: 10.3389/fphar.2024.1435524.

Shizao decoction for cirrhotic ascites: assessing potential targets based on network analysis combined with pharmacokinetics and metabolomics.

Li W, Hou Y, Wang Y, Liu R, Zhang H, Luo Y Front Pharmacol. 2024; 15:1298818.

PMID: 38323084 PMC: 10844526. DOI: 10.3389/fphar.2024.1298818.

Untargeted metabolite profiling of serum in rats exposed to pyrraline.

Hu C, Wang J, Qi F, Liu Y, Zhao F, Wang J Food Sci Biotechnol. 2023; 32(11):1541-1549.

PMID: 37637845 PMC: 10449741. DOI: 10.1007/s10068-023-01256-7.

Bioactive extracts and association with C and N in Eleutherococcus senticosus subjected to chitosan nanoparticles in contrasting light spectra.

Guo S, Wang H, Sui Y, Liu X, Tan L PLoS One. 2022; 17(12):e0277233.

PMID: 36454898 PMC: 9714952. DOI: 10.1371/journal.pone.0277233.

References

Zhang A, Sun H, Wang X . Potentiating therapeutic effects by enhancing synergism based on active constituents from traditional medicine. Phytother Res. 2013; 28(4):526-33. DOI: 10.1002/ptr.5032. View

Trepo C, Chan H, Lok A . Hepatitis B virus infection. Lancet. 2014; 384(9959):2053-63. DOI: 10.1016/S0140-6736(14)60220-8. View

Gong X, Zhang L, Jiang R, Wang C, Yin X, Wan J . Hepatoprotective effects of syringin on fulminant hepatic failure induced by D-galactosamine and lipopolysaccharide in mice. J Appl Toxicol. 2013; 34(3):265-71. DOI: 10.1002/jat.2876. View

Zhang A, Sun H, Qiu S, Wang X . NMR-based metabolomics coupled with pattern recognition methods in biomarker discovery and disease diagnosis. Magn Reson Chem. 2013; 51(9):549-56. DOI: 10.1002/mrc.3985. View

Zhang A, Sun H, Yan G, Yuan Y, Han Y, Wang X . Metabolomics study of type 2 diabetes using ultra-performance LC-ESI/quadrupole-TOF high-definition MS coupled with pattern recognition methods. J Physiol Biochem. 2013; 70(1):117-28. DOI: 10.1007/s13105-013-0286-z. View

Zhang A, Sun H, Wang Z, Sun W, Wang P, Wang X . Metabolomics: towards understanding traditional Chinese medicine. Planta Med. 2010; 76(17):2026-35. DOI: 10.1055/s-0030-1250542. View

Liu W, Liu Y . Youyou Tu: significance of winning the 2015 Nobel Prize in Physiology or Medicine. Cardiovasc Diagn Ther. 2016; 6(1):1-2. PMC: 4731589. DOI: 10.3978/j.issn.2223-3652.2015.12.11. View

Dong H, Zhang A, Sun H, Wang H, Lu X, Wang M . Ingenuity pathways analysis of urine metabolomics phenotypes toxicity of Chuanwu in Wistar rats by UPLC-Q-TOF-HDMS coupled with pattern recognition methods. Mol Biosyst. 2012; 8(4):1206-21. DOI: 10.1039/c1mb05366c. View

Zhang A, Sun H, Han Y, Yuan Y, Wang P, Song G . Exploratory urinary metabolic biomarkers and pathways using UPLC-Q-TOF-HDMS coupled with pattern recognition approach. Analyst. 2012; 137(18):4200-8. DOI: 10.1039/c2an35780a. View

10.

Zhang H, Zhang A, Zhou X, Sun H, Wang X, Liang L . High-throughput lipidomics reveal mirabilite regulating lipid metabolism as anticancer therapeutics. RSC Adv. 2022; 8(62):35600-35610. PMC: 9087915. DOI: 10.1039/c8ra06190d. View

11.

Qiu S, Zhang A, Zhang T, Sun H, Guan Y, Yan G . Dissect new mechanistic insights for geniposide efficacy on the hepatoprotection using multiomics approach. Oncotarget. 2018; 8(65):108760-108770. PMC: 5752478. DOI: 10.18632/oncotarget.21897. View

12.

Fang H, Zhang A, Sun H, Yu J, Wang L, Wang X . High-throughput metabolomics screen coupled with multivariate statistical analysis identifies therapeutic targets in alcoholic liver disease rats using liquid chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2019; 1109:112-120. DOI: 10.1016/j.jchromb.2019.01.017. View

13.

Cui Y, Zhang Y, Liu G . Syringin may exert sleep-potentiating effects through the NOS/NO pathway. Fundam Clin Pharmacol. 2014; 29(2):178-84. DOI: 10.1111/fcp.12095. View

14.

Wang X, Zhang A, Yan G, Sun W, Han Y, Sun H . Metabolomics and proteomics annotate therapeutic properties of geniposide: targeting and regulating multiple perturbed pathways. PLoS One. 2013; 8(8):e71403. PMC: 3744542. DOI: 10.1371/journal.pone.0071403. View

15.

Liu X, Zhang A, Fang H, Li M, Song Q, Su J . Serum metabolomics strategy for understanding the therapeutic effects of Yin-Chen-Hao-Tang against Yanghuang syndrome. RSC Adv. 2022; 8(14):7403-7413. PMC: 9078382. DOI: 10.1039/c7ra11048k. View

16.

Sun H, Zhang A, Song Q, Fang H, Liu X, Su J . Functional metabolomics discover pentose and glucuronate interconversion pathways as promising targets for Yang Huang syndrome treatment with Yinchenhao Tang. RSC Adv. 2022; 8(64):36831-36839. PMC: 9089300. DOI: 10.1039/c8ra06553e. View

17.

Yuan L, Wang T, Zhang Y, Liu X, Zhang T, Li X . An HBV-tolerant immunocompetent model that effectively simulates chronic hepatitis B virus infection in mice. Exp Anim. 2016; 65(4):373-382. PMC: 5111840. DOI: 10.1538/expanim.16-0013. View

18.

Xie J, Zhang A, Qiu S, Zhang T, Li X, Yan G . Identification of the perturbed metabolic pathways associating with prostate cancer cells and anticancer affects of obacunone. J Proteomics. 2019; 206:103447. DOI: 10.1016/j.jprot.2019.103447. View

19.

Zhang A, Sun H, Xu H, Qiu S, Wang X . Cell metabolomics. OMICS. 2013; 17(10):495-501. PMC: 3783970. DOI: 10.1089/omi.2012.0090. View

20.

Kim B, Kim M, Hyun C . Syringin attenuates insulin resistance via adiponectin-mediated suppression of low-grade chronic inflammation and ER stress in high-fat diet-fed mice. Biochem Biophys Res Commun. 2017; 488(1):40-45. DOI: 10.1016/j.bbrc.2017.05.003. View